IVIDATA LIFE SCIENCES : revenue, balance sheet and financial ratios

IVIDATA LIFE SCIENCES is a French company founded 12 years ago, specialized in the sector Activités spécialisées, scientifiques et techniques diverses. Based in PARIS (75009), this company of category PME shows in 2024 a revenue of 15.9 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - IVIDATA LIFE SCIENCES (SIREN 794189928)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue 15 895 757 € 18 651 633 € 21 463 534 € 19 620 484 € 17 364 845 € 13 496 461 € 10 920 977 € 6 354 553 € 3 350 016 €
Net income -499 171 € 134 643 € 2 083 217 € 2 140 988 € 2 032 511 € 1 619 146 € 1 796 118 € 1 820 681 € 213 170 €
EBITDA -2 054 938 € -1 707 797 € 142 287 € 351 486 € 594 126 € 470 608 € 846 143 € 1 844 493 € 313 745 €
Net margin -3.1% 0.7% 9.7% 10.9% 11.7% 12.0% 16.4% 28.7% 6.4%

Revenue and income statement

In 2024, IVIDATA LIFE SCIENCES achieves revenue of 15.9 M€. Over the period 2016-2024, the company shows strong growth with a CAGR (compound annual growth rate) of +21.5%. Significant drop of -15% vs 2023. After deducting consumption (0 €), gross margin stands at 15.9 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -2.1 M€, representing -12.9% of revenue. Warning negative scissor effect: despite revenue change (-15%), EBITDA varies by -20%, reducing margin by 3.8 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -499 k€ (-3.1% of revenue), which will impact equity.

Revenue (2024) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

15 895 757 €

Gross margin (2024) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

15 895 757 €

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-2 054 938 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-2 109 174 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-499 171 €

EBITDA margin (2024) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

-12.9%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 23%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 56%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

22.735%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

56.275%

Cash flow / Revenue (2024) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

-2.805%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

-3.249

Solvency indicators evolution
IVIDATA LIFE SCIENCES

Sector positioning

Debt ratio
22.73 2024
2022
2023
2024
Q1: 0.0
Med: 4.67
Q3: 40.89
Average

In 2024, the debt ratio of IVIDATA LIFE SCIENCES (22.73) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
56.27% 2024
2022
2023
2024
Q1: 4.58%
Med: 32.74%
Q3: 63.16%
Good +22 pts over 3 years

In 2024, the financial autonomy of IVIDATA LIFE SCIENCES (56.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
-3.25 years 2024
2022
2023
2024
Q1: 0.0 years
Med: 0.0 years
Q3: 0.43 years
Excellent -50 pts over 3 years

In 2024, the repayment capacity of IVIDATA LIFE SCIENCES (-3.25) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 326.49. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

326.491

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-6.727

Liquidity indicators evolution
IVIDATA LIFE SCIENCES

Sector positioning

Liquidity ratio
326.49 2024
2022
2023
2024
Q1: 144.63
Med: 259.05
Q3: 521.3
Good +23 pts over 3 years

In 2024, the liquidity ratio of IVIDATA LIFE SCIENCES (326.49) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
-6.73x 2024
2022
2023
2024
Q1: 0.0x
Med: 0.0x
Q3: 0.45x
Average -50 pts over 3 years

In 2024, the interest coverage of IVIDATA LIFE SCIENCES (-6.7x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 72 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 43 days. The company must finance 29 days of gap between collections and payments. Overall, WCR represents 158 days of revenue, i.e. 7.0 M€ to permanently finance. Over 2016-2024, WCR increased by +2021%, requiring additional financing.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

6 960 752 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

72 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

43 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR in days of revenue (2024) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

158 j

WCR and payment terms evolution
IVIDATA LIFE SCIENCES

Positioning of IVIDATA LIFE SCIENCES in its sector

Comparison with sector Activités spécialisées, scientifiques et techniques diverses

Valuation estimate

Based on 98 transactions of similar company sales (all years), the value of IVIDATA LIFE SCIENCES is estimated at 5 777 850 € (range 1 897 262€ - 9 776 450€). The price/revenue ratio is 0.36x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2024
98 tx
1897k€ 5777k€ 9776k€
5 777 850 € Range: 1 897 262€ - 9 776 450€
NAF 5 all-time

Valuation method used

Revenue Multiple
15 895 757 € × 0.36x = 5 777 851 €
Range: 1 897 263€ - 9 776 451€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 98 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Activités spécialisées, scientifiques et techniques diverses)

Compare IVIDATA LIFE SCIENCES with other companies in the same sector:

Voir toutes les statistiques du secteur Activités spécialisées, scientifiques et techniques diverses

Frequently asked questions about IVIDATA LIFE SCIENCES

What is the revenue of IVIDATA LIFE SCIENCES ?

The revenue of IVIDATA LIFE SCIENCES in 2024 is 15.9 M€.

Is IVIDATA LIFE SCIENCES profitable?

IVIDATA LIFE SCIENCES recorded a net loss in 2024.

Where is the headquarters of IVIDATA LIFE SCIENCES ?

The headquarters of IVIDATA LIFE SCIENCES is located in PARIS (75009), in the department Paris.

Where to find the tax return of IVIDATA LIFE SCIENCES ?

The tax return of IVIDATA LIFE SCIENCES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does IVIDATA LIFE SCIENCES operate?

IVIDATA LIFE SCIENCES operates in the sector Activités spécialisées, scientifiques et techniques diverses (NAF code 74.90B). See the 'Sector positioning' section above to compare the company with its competitors.